Rocket Pharmaceuticals, Inc. (RCKT) — SEC Filings
Rocket Pharmaceuticals, Inc. (RCKT) — 1 SEC filings. Latest: 8-K (Mar 27, 2026). Includes 1 8-K.
View Rocket Pharmaceuticals, Inc. on SEC EDGAR
Overview
Rocket Pharmaceuticals, Inc. (RCKT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Mar 27, 2026: Rocket Pharmaceuticals, Inc. filed an 8-K on March 27, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing includes an iXBRL 8-K document and exhibits such as EX-99.1 and graphic files, along with XBRL data files.
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Rocket Pharmaceuticals, Inc. is neutral.
Filing Type Overview
Rocket Pharmaceuticals, Inc. (RCKT) has filed 1 8-K with the SEC between Mar 2026.
Recent SEC Filings (1)
| Date | Form | Description | Risk |
|---|---|---|---|
| Mar 27, 2026 | 8-K | Rocket Pharmaceuticals Files 8-K | low |
Risk Profile
Risk Assessment: Of RCKT's 1 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 1 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
disclosure (1) · filing (1)
Frequently Asked Questions
What are the latest SEC filings for Rocket Pharmaceuticals, Inc. (RCKT)?
Rocket Pharmaceuticals, Inc. has 1 recent SEC filings from Mar 2026, including 1 8-K. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of RCKT filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Rocket Pharmaceuticals, Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Rocket Pharmaceuticals, Inc. (RCKT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Rocket Pharmaceuticals, Inc.?
Financial highlights for Rocket Pharmaceuticals, Inc. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for RCKT?
Investment thesis data for RCKT will be available once enriched filings are processed.
Who are the key executives at Rocket Pharmaceuticals, Inc.?
Executive information for Rocket Pharmaceuticals, Inc. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Rocket Pharmaceuticals, Inc. stock?
Of RCKT's 1 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Rocket Pharmaceuticals, Inc.?
Forward guidance and predictions for Rocket Pharmaceuticals, Inc. are extracted from SEC filings as they are enriched.